July 10, 2024 at 9:38 am
MindMed Joins Russell 2000® Index
Clinical stage biopharmaceutical company, MindMed (Nasdaq: MNMD) has been accepted to the Russell 2000® Index and the broad-market Russell 3000® Index. Membership in the Russell 3000® Index means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as in the appropriate growth and value style indexes. The company’s shares… [Read More]